Ligand Pharmaceuticals Inc.'s ticker is LGND and the CUSIP is 53220K207. A total of 3 filers reported holding Ligand Pharmaceuticals Inc. in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 52,900 | $1,978,000 | 1.52% |
| Baker Brothers Advisors | 73,400 | $2,745,000 | 0.05% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 6,800 | $254,000 | 0.00% |